Current Treatments for Alopecia Areata

    Maria Hordinsky
    Studysummary This review discusses recent therapeutic approaches for alopecia areata, including the use of Janus kinase inhibitors and interleukin-2, and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidsponline.org →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    2. Alopecia Areata: An Evidence-Based Treatment Update American journal of clinical dermatology · 2014
    3. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis Journal of Investigative Dermatology · 2014
    4. Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children JAMA dermatology · 2013
    5. The Safety and Efficacy of Diphencyprone for the Treatment of Alopecia Areata in Children Archives of dermatology · 2012
    6. Interventions for Alopecia Areata Cochrane library · 2008
    7. Treatment of Widespread Alopecia Areata in Young Patients with Monthly Oral Corticosteroid Pulse Pediatric Dermatology · 1998
    8. Alopecia Areata in Children: Response to Treatment with Diphencyprone British Journal of Dermatology · 1991

    Related research 10

    1. Efficacy of Janus Kinase Inhibitors in Adult Patients With Alopecia Areata International journal of research in dermatology · 2023
    2. Topical Tofacitinib in Treatment of Alopecia Areata Einstein (São Paulo) · 2020
    3. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature Journal of cutaneous medicine and surgery · 2019
    4. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study Dermatology · 2018
    5. Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata Drug design, development and therapy · 2018
    6. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib PubMed · 2018
    7. Tofacitinib 2% Ointment, a Topical Janus Kinase Inhibitor, for the Treatment of Alopecia Areata: A Pilot Study of 10 Patients Journal of the American Academy of Dermatology · 2017
    8. A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata Journal of cutaneous medicine and surgery · 2017
    9. Alopecia Areata: An Update on Treatment Options for Children Paediatric drugs · 2017
    10. Transient Efficacy of Tofacitinib in Alopecia Areata Universalis Case Reports in Dermatology · 2016